A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...

Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...

Mylan N.V. has announced that it has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide® Evohaler® (salmeterol xinafoate/fluticasone propionate) under the brand name Sirdupla™ ...

Glenmark Pharmaceuticals, a Rs. 6,000 crore plus pharma major, has received approval for Salmecort (salmeterol+fluticasone) MDI inhaler, from the Ministry of Health (MoH), Russia. The combination ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

AN URGENT inhaler recall has been issued for asthma sufferers with GPs warning they are failing to deliver the correct doses of medication, putting people's lives "at risk". The Medicines and ...

LONDON (MarketWatch) -- Lung-disease patients taking GlaxoSmithKline PLC's GSK asthma inhaler Seretide have better survival benefits than those taking a rival product, according to a study published ...

The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...